Pharmacology of attention and arousal in the low level patient

NeuroRehabilitation

Volumn 6, Issue 1, 1996, Pages 57-67

  Elovic, Elie ^a,b  

^a JFK Johnson Rehabilitative Institution   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Anticonvulsants; Antidepressants; Brain injury; Dopamine; Low level patient; Pharmacology; Stimulants

Indexed keywords

AMANTADINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BROMOCRIPTINE; CARBIDOPA PLUS LEVODOPA; DEXAMPHETAMINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; METHYLPHENIDATE; NEUROTRANSMITTER; NORADRENALIN; PEMOLINE MAGNESIUM; PERGOLIDE; SELEGILINE; SEROTONIN;

AGITATION; ANOREXIA; AROUSAL; ATTENTION; BRAIN INJURY; CHEMOPROPHYLAXIS; CHOLINERGIC SYSTEM; CONFUSION; DOPAMINERGIC SYSTEM; HUMAN; HYPERTENSION; INSOMNIA; IRRITABILITY; LIVER TOXICITY; MEDICAL LITERATURE; NAUSEA; NEUROANATOMY; NORADRENERGIC SYSTEM; PARANOIA; PHYSICIAN; REVIEW; SEIZURE; SEROTONINERGIC SYSTEM; SPASTICITY; TACHYCARDIA;

EID: 0030032370     PISSN: 10538135     EISSN: None     Source Type: Journal    
DOI: 10.1016/1053-8135(95)00148-4     Document Type: Review

References (53)

1. Plum F, Posner JB, Plum F, Posner JB, eds. The Diagnosis of Stupor and Coma, 3rd Ed. Philadelphia: F.A. Davis, 1982.
2. Whyte J. Neurologic disorders of attention - arousal: assessment and treatment. Arch Phys Med Rehabil 1992;73:1094-1103.
3. Whyte J. Attention and arousal: basic science aspects. Arch Phys Med Rehabil 1992;73:940-949.
4. LaBerge D, ed. Attentional Processing The Brain's Art of Mindfulness. Cambridge: Harvard University Press, 1995.
5. Mesulam M, ed. Attention, Confusional states and neglect. Principles of Behavioral Neurology. Philadelphia: F.A. Davis, 1985;125-168.
6. Robbins TW. Psychophamaclogical and Neurobehavioral aspects of the energetics of information processing. In: Hockey GRJ, Gaillard ARK and Coles MGH, eds. Energetics and Human Information Processing. Dordrecht: Martinus Nijhoff, 1986;71-90.
7. Auerbach SH. Neuroanatomical correlates of attention and memory disorders in traumatic brain injury: an application of neurobehavioral subtypes. J Head Trauma Rehabil 1986;1(3):1-12.
8. Cope DN. The pharmacology of attention and memory. J Head Trauma Rehabil 1986;1(3):34-42.
9. Hockey GRJ, Coles MGH, Galillard AWK. Energetical issues in research on human information processing. In: Hockey GRJ, Gaillard ARK, Coles MGH, eds. Energetics and Human Information Processing. Dordrecht: Martinus Nijhoff, 1986;3-21.
10. Cassidy JW. Neuropathology. In: Silver JM, Yudofsky SC, Hales RE, eds. Neuropsychiatry of Traumatic Brain Injury. Washington, D.C.: American Psychiatric Press, 1994;43-79.
11. Giacino JT, Keznarsky MA, Deluca J, et al. Monitoring rate of recovery to predict outcome in minimally responsive patients. Arch Phys Med Rehabil 1991;71(11):897-901.
12. Rappaport M, Hall KM, Hopkins K, et al. Disability Rating Scale for severe head trauma: coma to community. Arch Phys Med Rehabil 1982;63:118-123.
13. Wroblewski BA, Glenn MB. Pharmacological treatment of arousal and cognitive issues. J Head Trauma Rehabil 1994;9(3):19-42.
14. Gualtieri CT, ed. Neuropsychiartry and Behavioral Pharmacology. New York: Springer-Verlag, 1991.
15. Weinshenker BG, Penman M, Bass B, et al. A double blind, randomized, cross over trial of pemoline in fatigue associated with multiple sclerosis. Neurology 1992;42:1468-1471.
16. Gualtieri CT. Pharmacotherapy and the neurobehavioral sequalae of traumatic brain injury. Brain Injury 1988;2:101-129.
17. Evans RW, Gualtieri CT, Patterson D. Treatment of chronic closed head injury with psychostimulant drugs: a controlled case study and an appropriate evaluation procedure. J Nerv Ment Dis 1987;175:106-110.
18. Gualtieri CT, Evans RW. Stimulant treatment for the neurobehavioral sequelae of traumatic brain injury. Brain Injury 1988;2:273-290.
19. Kaelin DL, Citu DX, Matthies B. Methylphnidate for hypoarousal in the Brain-Injured Adult. Arch Phys Med Rehabil 1994;75(9):1030.
20. Feeney DM, Hovda DA. Amphetamine and apomorphine restore tactile placing after motor cortex injury in the cat. Psychopharmacology 1983;79:67-71.
21. Chandra B. Treatment of disturbances of consciousness created by measles encepthalitis with L-Dopa. Eur Neurol 1978;17:265-270.
22. Lal S, Merbitz CP, Grip JC. Modification of function in head-injured patients with sinemet. Brain Injury 1988;2(3):225-233.
23. Haig AJ, Ruess JM. Recovery from vegetative state of six month's duration associated with sinemet (levodopa/carbidopa). Arch Phys Med Rehabil 1990;71:1081-1083.
24. Dombovy ML, Wong A, Schneider W, et al. Clinical use of amantadine in brain injury rehabilitation. Arch Phys Med Rehabil 1992;73:975.
25. Chandler MC, Bamhill JL, Gualtieri CT. Amantadine for the agitated head-injury patient. Brain Injury 1988;2:309-311.
26. Horiguchi J, Inmi Y, Shoda T. Effects of long term amantadine treatment of clinical symptoms and EEG of a patient in a vegetative state. Clin Neuropharmacol 1990;13(1):84-88.
27. Gualtieri CT, Chandler M, Coons TB et al. Amantadine, a new clinical profile for traumatic brain injury. Clin Neuropharmacol 1989;12(4):258-270.
28. Crimson MI, Childs A, Wilcox RE, et al. The effect of bromocriptine on speech dysfunction in patients with diffuse brain injury (akinetic mutuism). Clin Neuropharmacol 1988;11:462-466.
29. Eames P. The use of sinemet and bromocriptine. Brain Injury 1989;3(3):319-320.
30. Barrett K. Treating organic abulia with bromocriptine and lisuride: four case studies. J Neurol Neurosurg Psychiatry 1991;54:718-722.
31. Crinison ML, Childs A, Wilcox RE, et al. The effects of bromocriptine on speech dysfunction in patients with diffuse brain injury (akinetic mutism). Clin Neuropharmacol 1988;11(5):462-466.
32. Anderson B. Relief of akinetic mutism from obstructive hydrocephalus using bromocriptine and ephedrine. J Neurosurg 1992;76:152-155.
33. Wroblewski BA, Glenn MB, Cornblatt R, et al. Protriptyline as an alternative stimulant medication in patients with brain injury: a series of case reports. Brain Injury 1993;7(4):353-362.
34. Gualtieri CT, Keenan PA, Chandler M. Clinical and neuropsychological effects of desipramine in children with attention defecit hyperactivity disorder. J Clin Psychopharmacol 1991;11:155-159.
35. Wroblewski BA, McColgan K, Smith K, et al. The incidence of seizures during tricyclic antidepressant drug treatment in a brain-injured population. J Clin Psychopharmacol 1990;10:124-128.
36. Robinson RG, Jorge R. Mood disorders. In: Silver JM, Yudofsky SC, Hales RE, eds. Neuropsychiatry of Traumatic Brain Injury. Washington, D.C.: American Psychiatric Press, 1994;219-250.
37. Silver JM, Yudofsky SC. Psychopharmacological approaches to the patient with affective and psychotic features. J Head Trauma Rehabil 1994;9(3):61-77.
38. Levine R, Kenin M, Hoffman JS, et al. Grand mal seizures associated with the use of flouxetine. J Clin Psychopharmacol 1994;14:145-146.
39. Cassidy JW. Neuropharmacolacological management of destructive behavior after traumatic brain injury. J Head Trauma Rehabil 1994;9(3):43-60.
40. Boyeson MG, Harmon RI. Effects of trazodone and desipramine on motor recovery in brain-injured rats. Am J Phys Med Rehabil 1993;72:286-293.
41. Rao N, Jellinek M, Woolston DC. Agitation in closed head injury: haloperidol effects on rehabilitation outcome. Arch Phys Med Rehabil 1985;66:30-34.
42. Goldstein LB. Common drugs may influence motor recovery after stroke. Neurology 1995;45(May):865-871.
43. Brailowsky S, Knight RT, Blood K. Gamma-aminobutyric acid induced potentiation of cortical hemiplegia. Brain Res 1986;362:322-330.
44. Brailowsky S, Knight RT, Efron R. Phenytoin increases the severity of cortical hemiplegia in rats. Brain Res 1986:376:71-77.
45. Schallert T, Hernandez TD, Barth TM. Recovery of function after brain injury: severe and chronic disruption by diazepam. Brain Res 1986;379:104-111.
46. Hernandez TD, Holling LC. Disruption of behavioral recovery by the anti-convulsant phenobaibital. Brain Res 1994;635:300-306.
47. Porch BE, Feeney DM. Effects of antihypertensive drugs on recovery from aphasia. Clin Aphasiol 1986;16:309-314.
48. Mena MA, Garcia de Yebenes MJ, Tabernero C, et al. Effects of calcium antagonists on the dopamine system. Clin Neuropharmacol 1995;18(5):410-426.
49. Personal communication Marion, D. 1995; The Role of Anti-Seizure Prophylaxis Following Head Injury.
50. Glotzner FL, Haubitz I, Miltner F, et al. Anfallsprophyylaze mit carbamazepin nach scheren schadelhirnverletzungen. Neurochirurgia 1983;26:66-79.
51. Temin NR, Dikmen SS, Wilensky M, et al. A randomized double blind study of phenytoin for the prevention of posttraumatic epilepsy. N Engl J Med 1990;323(8):497-502.
52. Dikmen SS, Temkin NR, Miller B, et al. Neurobehavioral effects of phenytoin prophylaxis of posttraumatic seizures. JAMA 1991;265(10):1271-1277.
53. Pechadre JC, Lauaxerois M, Colnet G, et al. Prevention de l'epelepsie post-traumatigue tardive par phenytoine dans les traumatismes carniens grave: Suivi durant 2 ans. Presse Med 1991;20:841-845.